Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyound anecdotal evidence?

被引：22

作者：

Carmona A. ^{[1
]}

Alonso J.D. ^{[1
]}

de las Heras M. ^{[2
]}

Navarrete A. ^{[1
]}

机构：

[1] Medical Oncology Department, Virgen Arrixaca University Hospital, El Palmar, Murcia, Ctra. Madrid-Cartagenal s/n

[2] Radiation Oncology Department, Virgen Arrixaca University Hospital, El Palmar, Murcia, Ctra. Madrid-Cartagenal s/n

来源：

Clinical and Translational Oncology | 2006年 / 8卷 / 10期

关键词：

Cancer; Guilain-Barre syndrome; Lymphoma; Maintenance; Paraneoplastic syndromes; Polyneuropathy; Rituximab;

D O I：

10.1007/s12094-006-0126-5

中图分类号：

学科分类号：

摘要：

Paraneoplastic neurological syndromes constitute an unusual manifestation of cancer. The objective of this case report is to debate the association between rituximab therapy and Guillain-Barre syndrome. We present the case of a 57 years old patient, with diffuse large-B cell lymphoma in complete remission, who consulted our hospital because of symmetric lower extremity weakness, developed while being treated with a rituximab maintenance schedule. Our main conclusion is that plasma cell dysregulation due to rituximab should be clarified in future studies. © FESEO 2006.

引用

页码：764 / 766

页数：2

共 28 条

[1]

Vedeler C.A., Inflammatory neuropathy: Update, Curr Opin Neurol., 13, pp. 305-309, (2000)

[2]

Asbury A., Arnason B.G., Adams R.D., The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis, Medicine, 48, pp. 173-215, (1969)

[3]

Hadden R.D., Cornblath D.R., Hughes R.A., Et al., Electrophysiological classification of Guilain-Barre syndrome: Clinical associations and outcome, Ann Neurol., 44, pp. 780-788, (1998)

[4]

Hafer-Macko C., Hsieh S.T., Li G.Y., Et al., Acute motor axonal neuropathy: An antibody-mediated attack on axolemma, Ann Neurol., 40, pp. 644-655, (1996)

[5]

Winer J.B., Kangro R.A., Anderson M.J., Jones D.M., Kangro H., Watkins R.P., A prospective study of acute idiopathic neuropathy. II. Antecedent events, J Neurol Neurosurg Psychiatry, 51, pp. 613-618, (1988)

[6]

Hahn A.F., Guillatin-Barre syndrome, Lancet, 352, 9128, pp. 635-641, (1998)

[7]

Waksman B.H., Adams R.D., Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants, J Exp Med., 102, (1955)

[8]

Vigliani M.C., Magistrello M., Polo P., Mutani R., Chio A., Risk of cancer in patients with Guillain-Barre syndrome (GBS). A population-based study. Piemonte and Valle d'Aosta Register for Guillain-Barre Syndrome, J Neurol., 25, 3, pp. 321-326, (2004)

[9]

Zuk E., Nowacki P., Fabian A., Guillain-Barre syndrome in patient with Burkitt's lymphoma and type 2 diabetes mellitus, Folia Neuropathol., 39, 4, pp. 281-284, (2001)

[10]

Toren A., Mandel M., Shahar E., Rimmoni E., Primary central newrvous system Burkitt's lymphoma presenting as Guillain-Barre syndrome, Med Pediatr Oncol., 25, 4, pp. 372-375, (1994)

← 1 2 3 →